Skip to content
★ Sign in to follow
Qurient Co., Ltd. logo

Qurient Co., Ltd. Stock: price and insider trades · South Korea

큐리언트

KR·Mcap ₩637.3BHealth Care

8 insiders bought shares over the last 90 days, the latest by 박태식, filed 05 Nov 2026.

Cluster: 8 buyers in 30 days
Insider Decl.
118
Thresholds
n/a
Buy Volume
€178M
46 ops. · all time
Sell Volume
€12M
7 ops. · all time

Who traded when

BuySale
김정준4 buys
임현진4 buys
동구바이오제약1 buy2 sales
유창연3 buys
허태석3 buys
남기연2 buys

+6 other insiders

Since the insiders bought

  • Filed 30 Apr 2026 · 193 days ago · €59k
    -54.7%
    Entry ₩34,950 · Close 03 Nov 2026 ₩15,840
  • Filed 30 Apr 2026 · 193 days ago · €42k
    -54.7%
    Entry ₩34,950 · Close 03 Nov 2026 ₩15,840
  • Filed 30 Apr 2026 · 193 days ago · €59k
    -54.7%
    Entry ₩34,950 · Close 03 Nov 2026 ₩15,840

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 25,532 of 26,913 companies
15.7
score / 100
Value
22
Quality
9
FCF yld-5.4%
Earn yld-5.0%
EV/EBITDA·
ROE-102%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩16,160
Analyst consensus
·
Income statement
Revenue₩7B
Gross profit₩929.9M13% margin
EBITDA-₩30B-429% margin
Net income-₩30.1B-430.4% margin
Valuation
Beta0.57
Balance sheet & cash
Market cap₩637.3B
Total debt₩12.7B
Free Cash Flow-₩32.4B
Debt / Equity61%
Profitability & ownership
ROE-102.0%
ROA-43.5%
% insiders26.0%
% institutions6.5%
Last declaration on 5 November 2026
Declarations127 total
  • Other
    Other(filed)
    0DART
  • ▲
    독립이사Executives(filed)
    0DART
    565 sharesShareKRXDART:20261105000131
    Canonical exit: 3 Feb 2027 (T+90)
  • ▲
    기타비상무이사Executives(filed)
    0DART
    4,901 sharesShareKRXDART:20261105000130
    Canonical exit: 3 Feb 2027 (T+90)
  • ▲
    이사Executives(filed)
    0DART
    6,432 sharesShareKRXDART:20261105000129
    Canonical exit: 3 Feb 2027 (T+90)
  • ▲
    상무이사Executives(filed)
    0DART
    22,789 sharesShareKRXDART:20261105000128
    Canonical exit: 3 Feb 2027 (T+90)
  • ▲
    전무이사Executives(filed)
    0DART
    27,142 sharesShareKRXDART:20261105000127
    Canonical exit: 3 Feb 2027 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    51,541 sharesShareKRXDART:20261105000126
    Canonical exit: 3 Feb 2027 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    31,878 sharesShareKRXDART:20261105000125
    Canonical exit: 3 Feb 2027 (T+90)
  • ▲
    대표이사Executives(filed)
    0DART
    88,355 sharesShareKRXDART:20261105000124
    Canonical exit: 3 Feb 2027 (T+90)
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    부사장Executives(filed)
    €90kest.0DART
    10,000 sharesShareKRXDART:20260730000084
    Canonical exit: 28 Oct 2026 (T+90)
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▼
    대량보유자Executives(filed)
    €24kest.0DART
    2,000 sharesKRXDART:20260623000267
  • ▼
    Related company / holdingExecutives(filed)
    €25kest.0DART
    2,000 sharesKRXDART:20260622000345
  • ▲
    이사Executives
    103M KRW33DART
    17,000 shares@ ₩6,053.000.010% mcap100.0% of flowShareKRXDART:20260430001230
    Canonical exit: 28 Jul 2026 (T+90)
  • ▲
    부사장Executives
    73M KRW37DART
    12,000 shares@ ₩6,053.000.0072% mcap100.0% of flowShareKRXDART:20260430001281
    Canonical exit: 29 Jul 2026 (T+90)
  • ▲
    전무이사Executives
    103M KRW33DART
    17,000 shares@ ₩6,053.000.010% mcap100.0% of flowShareKRXDART:20260430001274
    Canonical exit: 28 Jul 2026 (T+90)
  • ▲
    상무이사Executives
    70M KRW33DART
    11,564 shares@ ₩6,053.000.0069% mcap100.0% of flowShareKRXDART:20260430001257
    Canonical exit: 28 Jul 2026 (T+90)
  • ▲
    감사Executives
    75M KRW15DART
    2,000 shares@ ₩37,370.500.0072% mcap100.0% of flowShareKRXDART:20260403001983
    Canonical exit: 30 Jun 2026 (T+90)

25 of 127 declarations

About Qurient Co., Ltd.

April 1 to April 30, 2026 frames the busiest buying window at Qurient Co., Ltd. (큐리언트): 5 filers bought there, for EUR 243,170 in total. The two largest purchases are dated April 29, 2026, EUR 59,168 each, for 허태석 (이사) and 임현진 (전무이사); 김성우, 감사, follows with EUR 42,602 on April 1.

Across the whole record, the 110 filings break down into 38 purchases and 7 sales, or 84% purchases among open-market trades. The heaviest sale, EUR 2,377,012 on February 3, 2023, comes from 쿼드자산운용. 동구바이오제약, filed as 대량보유자, is the most active filer with 63 filings, 6 of them purchases and 2 sales.

Read moreShow less

This South Korean health care company, with a market capitalisation of KRW 761.1 billion, saw 32 filings in 2023 and 4 in 2025. Over the last twelve months: 21 filings, 15 purchases, 4 sales. For 28 purchases a 90-day result is stored: a median of minus 4.4%, with 36% of results positive. These are recorded past results, not a forecast.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations